Ryan Feaver

Ryan Feaver

Company: HemoShear Therapeutics, Inc.

Job title: Program Director


Novel Target Identification & Validation Using Complex in vitro Models & Computational Biology in NASH. 2:00 pm

• Capturing critical pathophysiologic drivers of NASH to recapitulate human disease in vitro • Utilizing diverse computational biology approaches to identify novel targets • Validating and systematically rank targets for pipeline decision-making and prioritization Ryan Feaver, Program Director, HemoShear TherapeuticsRead more

day: Day 1 Stream 1 PM

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.